Imexpharm Corp 2023 SR
The report highlights Imexpharm's 2023 performance, achieving a record gross revenue of VND 2,113.9 billion and a 30% increase in pre-tax profit. The company operates 11 EU-GMP production lines, the highest in Vietnam, and successfully commenced commercial operations at its state-of-the-art IMP4 plant. Key sustainability achievements include a 15% increase in average employee income, providing employment for 1,405 individuals, and maintaining a 50% female representation on the Board of Directors. Imexpharm also demonstrated environmental commitment by reducing energy intensity by 29% and ensuring 100% wastewater treatment compliance. The report follows GRI 2021 Standards and aligns with the UN Sustainable Development Goals.
Company: Imexpharm Corp
Sector: Manufacturing
Country: Vietnam
Year: 2023
Type: SR
Pages: 71
Back to company
Imexpharm Corp
Sustainable Development Report
The report highlights Imexpharm's 2023 performance, achieving a record gross revenue of VND 2,113.9 billion and a 30% increase in pre-tax profit. The company operates 11 EU-GMP production lines, the highest in Vietnam, and successfully commenced commercial operations at its state-of-the-art IMP4 plant. Key sustainability achievements include a 15% increase in average employee income, providing employment for 1,405 individuals, and maintaining a 50% female representation on the Board of Directors. Imexpharm also demonstrated environmental commitment by reducing energy intensity by 29% and ensuring 100% wastewater treatment compliance. The report follows GRI 2021 Standards and aligns with the UN Sustainable Development Goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees